Compare ACET & NTIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACET | NTIC |
|---|---|---|
| Founded | 1947 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.3M | 82.5M |
| IPO Year | N/A | N/A |
| Metric | ACET | NTIC |
|---|---|---|
| Price | $8.58 | $9.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $65.33 | N/A |
| AVG Volume (30 Days) | ★ 208.6K | 24.4K |
| Earning Date | 03-05-2026 | 01-08-2026 |
| Dividend Yield | N/A | ★ 0.44% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $86,204,962.00 |
| Revenue This Year | N/A | $11.40 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.15 | $6.75 |
| 52 Week High | $17.44 | $12.53 |
| Indicator | ACET | NTIC |
|---|---|---|
| Relative Strength Index (RSI) | 78.42 | 56.77 |
| Support Level | $7.76 | $8.96 |
| Resistance Level | $8.55 | $9.97 |
| Average True Range (ATR) | 0.45 | 0.54 |
| MACD | -0.14 | 0.02 |
| Stochastic Oscillator | 73.85 | 57.21 |
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
Northern Technologies International Corp is a United States-based firm that develops and markets proprietary, environmentally beneficial products and services world wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments, which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company. The company generates the majority of its revenue in the United States.